Zen Principle Moringa Capsules Recalled for Salmonella Contamination

Zen Principle Recalls Moringa Capsules After FDA Detects Salmonella in Raw Ingredient

Relay Peak Research LLC, doing business as Zen Principle Naturals, has voluntarily recalled one lot of its Zen Principle® Moringa Capsules after learning that the raw moringa leaf powder used to manufacture the product tested positive for Salmonella.

The recall affects a single lot of 180-count Moringa Leaf Powder Capsules (Lot A6FF4, Best By 11/2028) distributed nationwide between December 2025 and July 2026 through Amazon, the company’s website, and limited sales on eBay and Etsy.

No illnesses have been reported.

FDA Testing Traced the Problem to the Ingredient Supplier

Unlike many food recalls that begin after consumer illnesses or routine testing of finished products, this recall originated upstream in the supply chain.

According to the company’s announcement, the recall was initiated after its ingredient supplier notified Zen Principle that FDA testing of the moringa leaf powder supplied for manufacturing had tested positive for Salmonella.

That contaminated ingredient was used to manufacture a single finished product lot.

Once notified, the company halted distribution and initiated a voluntary recall while cooperating with FDA. This distinction is important because it suggests the contamination was identified before widespread illness occurred, demonstrating how regulatory sampling can detect hazards before they reach more consumers.

What Consumers Should Do

Consumers who purchased the recalled lot should stop using the product immediately, dispose of the product, and contact Zen Principle Naturals for a refund.

Consumers do not need to return the product to receive a refund.

Why Salmonella Matters

Salmonella is one of the most common causes of foodborne illness in the United States. Healthy adults often experience fever, diarrhea, nausea, vomiting, and abdominal pain.

Infections can become far more serious in young children, older adults, pregnant individuals, and people with weakened immune systems.

In severe cases, Salmonella can enter the bloodstream and cause life-threatening complications, including infected aneurysms, endocarditis, and arthritis.

Although dietary supplements are frequently perceived as “natural” products, they remain vulnerable to the same microbial contamination risks that affect foods, herbs, spices, and other agricultural products.

MDP Analysis

Perhaps the most significant aspect of this recall is how the contamination was discovered.

According to the company’s announcement, FDA testing detected Salmonella in the raw moringa leaf powder before the issue was identified through consumer illnesses or finished-product testing. The ingredient supplier then notified the manufacturer, which voluntarily recalled the affected lot.

This represents preventive food safety in action. Rather than responding to an outbreak, FDA surveillance identified contamination upstream in the supply chain, allowing corrective action before illnesses were reported.

For dietary supplement manufacturers, the recall serves as a reminder that product safety begins long before capsules are filled or bottles are labeled. Agricultural ingredients can acquire microbial contamination during cultivation, harvesting, drying, storage, or transportation. Manufacturers therefore depend not only on their own quality systems, but also on robust supplier qualification, ingredient testing, and effective communication throughout the supply chain.

Viewed alongside other recent moringa-related safety actions, this recall also raises broader questions about ingredient sourcing and microbial controls for botanical products.

Whether these events represent isolated incidents or signal elevated risks within portions of the moringa supply chain remains unclear. What is clear is that FDA’s surveillance system detected this contamination at the ingredient level, which demonstrates the value of preventive oversight in protecting consumers before illnesses occur.